Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 73
Filter
1.
Int J Biol Macromol ; 255: 127988, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37956809

ABSTRACT

In this study, we constructed a novel powder-laden core-shell crosslinked chitosan microneedle patch for high-dose and controllable delivery of various drugs, including both macromolecular biological drugs and small-molecule chemical drugs. Direct loading of drug powders greatly improved drug loading capacity and minimized degradation. The results of the in vitro drug release study suggested that the release behaviors of the most tested drugs (both macromolecular drugs and small-molecule drugs) can be tuned by adjusting the crosslink density of the microneedle shell to achieve either rapid or sustained release of the loaded drug. The in vivo hypoglycemic efficacy test in streptozotocin-induced diabetic mice further proved that the onset and duration of the insulin-laden patch can be customized by adjusting the crosslink density. Furthermore, a combination of microneedle patches with different crosslink densities not only rapidly reduced blood glucose levels to normoglycemic levels (within 1 h) but also maintained normoglycemia for up to 36 h. The insulin loaded in the patch also showed good stability during storage at 40 °C for 6 months. Our results suggest that this powder-laden patch represents a strong candidate for addressing the multiple challenges in the preparation and application of polymeric microneedles and shows promise in clinical applications.


Subject(s)
Chitosan , Diabetes Mellitus, Experimental , Mice , Animals , Chitosan/chemistry , Powders , Diabetes Mellitus, Experimental/drug therapy , Needles , Drug Delivery Systems/methods , Insulin/pharmacology , Macromolecular Substances/therapeutic use , Administration, Cutaneous
2.
Int J Mol Sci ; 24(16)2023 Aug 21.
Article in English | MEDLINE | ID: mdl-37629199

ABSTRACT

Sepsis is associated with high rates of mortality in the intensive care unit and accompanied by systemic inflammatory reactions, secondary infections, and multiple organ failure. Biological macromolecules are drugs produced using modern biotechnology to prevent or treat diseases. Indeed, antithrombin, antimicrobial peptides, interleukins, antibodies, nucleic acids, and lentinan have been used to prevent and treat sepsis. In vitro, biological macromolecules can significantly ameliorate the inflammatory response, apoptosis, and multiple organ failure caused by sepsis. Several biological macromolecules have entered clinical trials. This review summarizes the sources, efficacy, mechanism of action, and research progress of macromolecular drugs used in the prevention and treatment of sepsis.


Subject(s)
Multiple Organ Failure , Sepsis , Humans , Sepsis/drug therapy , Sepsis/prevention & control , Antibodies , Anticoagulants , Antimicrobial Peptides , Macromolecular Substances/therapeutic use
3.
BioDrugs ; 36(6): 687-700, 2022 Nov.
Article in English | MEDLINE | ID: mdl-36282433

ABSTRACT

Oral administration of macromolecules aimed at systemic delivery has been at the forefront of pharmaceutical research for over 50 years. Yet, in terms of clinical translation for systemic delivery, output is limited to five US Food and Drug Administration (FDA)-approved oral peptide products to date, such are the hurdles. Somewhat neglected by comparison but with potentially lower delivery demands, the goal of local delivery of macromolecules directed mostly to the terminal ileum and colon to treat inflammatory bowel conditions has led to a range of macromolecules including gut-restricted peptides, fusion proteins, enzymes, antibodies, and antisense oligonucleotides that have reached clinical trials. While some of these trials reached primary endpoints, others are at early clinical stages, but it is likely that at least a few approvable products will emerge to supplement the current cohort of parenterally administered macromolecules and oral small molecules. The outstanding successes to date are the FDA approvals of two gut-restricted guanylate cyclase C-activating peptides to treat irritable bowel syndrome (constipated). Over-expressed targets for macromolecules in the gut wall of inflammatory bowel disease patients include α4ß7 integrin, TNF-α, CD-3, ICAM-1, and SMAD-7, while reduced responses to IL-10 and melanocortin offer opportunities for macromolecular agonists. In this Leading Article, a landscape of locally delivered macromolecules to access the gut that have recently reached clinical trials is provided.


Subject(s)
Inflammatory Bowel Diseases , Humans , Administration, Oral , Inflammatory Bowel Diseases/drug therapy , Intestine, Large , Macromolecular Substances/therapeutic use , Peptides/therapeutic use , Clinical Trials as Topic
4.
Adv Sci (Weinh) ; 9(12): e2104696, 2022 04.
Article in English | MEDLINE | ID: mdl-35195372

ABSTRACT

Current pharmacotherapy is challenged by side effects and drug resistance issues due to the lack of drug selectivity. Mechanochemistry-based strategies provide new avenues to overcome the related problems by improving drug selectivity. It is recently shown that sonomechanical bond scission enables the remote-controlled drug release from their inactive parent macromolecules using ultrasound (US). To further expand the scope of the US-controlled drug activation strategy, herein a mechano-responsive nanoswitch for the selective activation of doxorubicin (DOX) to inhibit cancer cell proliferation is constructed. As a proof-of-concept, the synthesis, characterization, and US-responsive drug activation evaluation of the mechano-nanoswitch, which provides a blueprint for tailoring nanosystems for force-induced pharmacotherapy is presented.


Subject(s)
Doxorubicin , Neoplasms , Activation, Metabolic , Doxorubicin/chemistry , Doxorubicin/pharmacology , Doxorubicin/therapeutic use , Drug Liberation , Humans , Macromolecular Substances/therapeutic use , Neoplasms/diagnostic imaging , Neoplasms/drug therapy
5.
Int J Biol Macromol ; 188: 82-93, 2021 Oct 01.
Article in English | MEDLINE | ID: mdl-34363823

ABSTRACT

World Health Organization estimates that 30-50% of cancers are preventable by healthy lifestyle choices, early detection and adequate therapy. When the conventional therapeutic strategies are still regulated by the lack of selectivity, multidrug resistance and severe toxic side effects, nanotechnology grants a new frontier for cancer management since it targets cancer cells and spares healthy tissues. This review highlights recent studies using biotin molecule combined with functional nanomaterials used in biomedical applications, with a particular attention on biotinylated chitosan-based nanosystems. Succinctly, this review focuses on five areas of recent advances in biotin engineering: (a) biotin features, (b) biotinylation approaches, (c) biotin functionalized chitosan based nanosystems for drug and gene delivery functions, (d) diagnostic and theranostic perspectives, and (e) author's inputs to the biotin-chitosan based tumour-targeting drug delivery structures. Precisely engineered biotinylated-chitosan macromolecules shaped into nanosystems are anticipated to emerge as next-generation platforms for treatment and molecular imaging modalities applications.


Subject(s)
Chitosan/chemistry , Macromolecular Substances/chemistry , Nanostructures/chemistry , Neoplasms/drug therapy , Biotin/chemistry , Biotinylation , Chitosan/therapeutic use , Drug Delivery Systems , Humans , Macromolecular Substances/therapeutic use , Molecular Imaging , Nanostructures/therapeutic use , Nanotechnology/trends
6.
ACS Appl Mater Interfaces ; 13(28): 32729-32742, 2021 Jul 21.
Article in English | MEDLINE | ID: mdl-34247476

ABSTRACT

Aristolochic acid (AA) has been reported to cause a series of health problems, including aristolochic acid nephropathy and liver cancer. However, AA-containing herbs are highly safe in combination with berberine (Ber)-containing herbs in traditional medicine, suggesting the possible neutralizing effect of Ber on the toxicity of AA. In the present study, in vivo systematic toxicological experiments performed in zebrafish and mice showed that the supramolecule self-assembly formed by Ber and AA significantly reduced the toxicity of AA and attenuated AA-induced acute kidney injury. Ber and AA can self-assemble into linear heterogenous supramolecules (A-B) via electrostatic attraction and π-π stacking, with the hydrophobic groups outside and the hydrophilic groups inside during the drug combination practice. This self-assembly strategy may block the toxic site of AA and hinder its metabolism. Meanwhile, A-B linear supramolecules did not disrupt the homeostasis of gut microflora as AA did. RNA-sequence analysis, immunostaining, and western blot of the mice kidney also showed that A-B supramolecules almost abolished the acute nephrotoxicity of AA in the activation of the immune system and tumorigenesis-related pathways.


Subject(s)
Aristolochic Acids/toxicity , Berberine/therapeutic use , Drugs, Chinese Herbal/toxicity , Kidney Diseases/prevention & control , Macromolecular Substances/therapeutic use , Animals , Aristolochic Acids/chemistry , Berberine/chemistry , Drug Interactions , Drugs, Chinese Herbal/chemistry , Dysbiosis/prevention & control , Gastrointestinal Microbiome/drug effects , Gene Expression/drug effects , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Kidney Diseases/chemically induced , Kidney Diseases/pathology , Killer Cells, Natural/drug effects , Macromolecular Substances/chemistry , Macromolecular Substances/toxicity , Male , Mice, Inbred C57BL , Neutrophils/drug effects , Transcription Factor RelA/metabolism , Zebrafish , p38 Mitogen-Activated Protein Kinases/metabolism
7.
Molecules ; 26(4)2021 Feb 07.
Article in English | MEDLINE | ID: mdl-33562215

ABSTRACT

Therapeutic proteins, such as growth factors (GFs), have been used in tissue engineering (TE) approaches for their ability to provide signals to cells and orchestrate the formation of functional tissue. However, to be effective and minimize off-target effects, GFs should be delivered at the target site with temporal control. In addition, protein drugs are typically sensitive water soluble macromolecules with delicate structure. As such, hydrogels, containing large amounts of water, provide a compatible environment for the direct incorporation of proteins within the hydrogel network, while their release rate can be tuned by engineering the network chemistry and density. Being formed by transient crosslinks, afforded by non-covalent interactions, supramolecular hydrogels offer important advantages for protein delivery applications. This review describes various types of supramolecular hydrogels using a repertoire of diverse building blocks, their use for protein delivery and their further application in TE contexts. By reviewing the recent literature on this topic, the merits of supramolecular hydrogels are highlighted as well as their limitations, with high expectations for new advances they will provide for TE in the near future.


Subject(s)
Hydrogels/chemistry , Intercellular Signaling Peptides and Proteins/chemistry , Proteins/chemistry , Tissue Engineering , Humans , Hydrogels/therapeutic use , Intercellular Signaling Peptides and Proteins/therapeutic use , Macromolecular Substances/chemistry , Macromolecular Substances/therapeutic use , Proteins/therapeutic use , Water/chemistry
8.
J Mater Sci Mater Med ; 32(1): 17, 2021 Jan 27.
Article in English | MEDLINE | ID: mdl-33506368

ABSTRACT

Osteoporosis is the most common disease involving bone degeneration. As the age of the population increases, the prevalence of the disease is expected to rise. However, current treatment methods do not provide a desirable solution for the restoration of the function of degenerated bones in patients with osteoporosis. This led to emergence of controlled delivery systems to increase drug bioavailability and efficacy specifically at the bone regeneration. In this study, an epimedin A (EA) complex drug system was prepared by solution blending method. In vitro cell-based experiments showed that the EA complex drug could significantly promote the differentiation and proliferation of osteoblasts and increase the alkaline phosphatase activity, calcium nodule formation, and the expression of osteogenesis-related genes and proteins. In vivo experiments further demonstrated that this novel drugs remarkably enhanced bone regeneration. These results suggest that EA may be used for the treatment of osteoporosis.


Subject(s)
Drug Carriers , Flavonoids/administration & dosage , Osteoporosis/drug therapy , Animals , Bone Density/drug effects , Cell Differentiation/drug effects , Cells, Cultured , Delayed-Action Preparations , Disease Models, Animal , Drug Carriers/chemical synthesis , Drug Carriers/chemistry , Drug Carriers/pharmacokinetics , Drug Carriers/therapeutic use , Drug Liberation , Female , Flavonoids/chemistry , Flavonoids/pharmacokinetics , Macromolecular Substances/chemical synthesis , Macromolecular Substances/chemistry , Macromolecular Substances/pharmacokinetics , Macromolecular Substances/therapeutic use , Mice , Osteoblasts/drug effects , Osteoblasts/physiology , Osteogenesis/drug effects , Osteoporosis/metabolism , Osteoporosis/pathology , Ovariectomy , Polysaccharides, Bacterial/chemistry , Sulfhydryl Compounds/chemistry
9.
Int J Biol Macromol ; 171: 398-413, 2021 Feb 28.
Article in English | MEDLINE | ID: mdl-33422516

ABSTRACT

Diatoms are ubiquitous, biologically widespread, and have global significance due to their unique silica cell wall composition and noteworthy applied aspects. Diatoms are being extensively exploited for environmental monitoring, reconstruction, and stratigraphic correlation. However, considering all the rich elements of diatoms biology, the current literature lacks sufficient information on the therapeutic attributes and applied aspects of biological macromolecules from diatoms, hampering added advances in all aspects of diatom biology. Diatoms offer numerous high-value compounds, such as fatty acids, polysaccharides, polypeptides, pigments, and polyphenols. Diatoms with a high content of PUFA's are targets of transformation into high-value products through microalgal technologies due to their wide application and growing market as nutraceuticals and food supplements. Diatoms are renewable biomaterial, which can be used to develop drug delivery systems due to biocompatibility, surface area, cost-effective ratio, and ease in surface modifications. Innovative approaches are needed to envisage cost-effective ways for the isolation of bioactive compounds, enhance productivity, and elucidate the detailed mechanism of action. This review spotlights the notable applications of diatoms and their biologically active constituents, such as fucoxanthin and omega 3 fatty acids, among others with unique structural and functional entities.


Subject(s)
Diatoms/chemistry , Macromolecular Substances/therapeutic use , Dietary Supplements , Drug Delivery Systems , Fatty Acids/isolation & purification , Fatty Acids/therapeutic use , Humans , Macromolecular Substances/economics , Macromolecular Substances/isolation & purification , Peptides/isolation & purification , Peptides/therapeutic use , Polyphenols/isolation & purification , Polyphenols/therapeutic use , Polysaccharides/isolation & purification , Polysaccharides/therapeutic use , Protective Agents/therapeutic use , Sterols/isolation & purification , Sterols/therapeutic use , Xanthophylls/isolation & purification , Xanthophylls/therapeutic use
10.
Biomolecules ; 11(1)2020 12 26.
Article in English | MEDLINE | ID: mdl-33375231

ABSTRACT

Special Issue "2019 Feature Papers by Biomolecules' Editorial Board Members" represents a set of papers based on the results of the research in the laboratories of the Editorial Board Members (EBMs) of Biomolecules focused (a big surprise!) on different aspects of biomolecules [...].


Subject(s)
Macromolecular Substances/chemistry , Humans , Macromolecular Substances/therapeutic use
11.
Int J Mol Sci ; 21(11)2020 May 31.
Article in English | MEDLINE | ID: mdl-32486445

ABSTRACT

: Many synthetic drugs and monoclonal antibodies are currently in use to treat Inflammatory Bowel Disease (IBD). However, they all are implicated in causing severe side effects and long-term use results in many complications. Numerous in vitro and in vivo experiments demonstrate that phytochemicals and natural macromolecules from plants and animals reduce IBD-related complications with encouraging results. Additionally, many of them modify enzymatic activity, alleviate oxidative stress, and downregulate pro-inflammatory transcriptional factors and cytokine secretion. Translational significance of natural nanomedicine and strategies to investigate future natural product-based nanomedicine is discussed. Our focus in this review is to summarize the use of phytochemicals and macromolecules encapsulated in nanoparticles for the treatment of IBD and IBD-associated colorectal cancer.


Subject(s)
Biological Products/therapeutic use , Inflammatory Bowel Diseases/therapy , Nanomedicine , Animals , Benzoquinones/therapeutic use , Biomimetics , Caffeic Acids/therapeutic use , Curcumin/therapeutic use , Cytokines/metabolism , Exosomes/chemistry , Zingiber officinale/metabolism , Humans , Inflammation/drug therapy , Insecta , Macromolecular Substances/therapeutic use , Oxidative Stress , Phenylethyl Alcohol/analogs & derivatives , Phenylethyl Alcohol/therapeutic use , Phytochemicals/therapeutic use , Plant Extracts/therapeutic use , Polysaccharides/therapeutic use , Quercetin/therapeutic use , Resveratrol/therapeutic use , Stilbenes/therapeutic use , Transcription Factors/metabolism , Translational Research, Biomedical , Vasoactive Intestinal Peptide/therapeutic use
12.
Int J Biol Macromol ; 156: 906-917, 2020 Aug 01.
Article in English | MEDLINE | ID: mdl-32234447

ABSTRACT

The extraction process of Glycyrrhiza soluble polysaccharide (GP) was optimized by RSM, a rat trauma model was established via longitudinal incision on the back skin. The effects of GP combined with microcapsule collagen on the repair of rat injury model were discussed at different levels, Based on the content of hydroxyproline at the whole animal level, the proliferation of granulation tissue stained by HE, the number of microvessels labeled by CD34, the production of collagen fibers stained by Masson, the level of phosphorylation of STAT3 protein and that of VEGF at protein level were investigated. The results showed that after the administration of GP combined with microcapsules, the content of hydroxyproline in granulation tissue increased, the proliferation of capillaries and fibroblasts in granulation tissue became active, and the number of microvessels in wound increased. The formation density of collagen fibers was uniform and orderly. GP combined with microcapsules could activate the expression of p-STAT3 and VEGF proteins and up-regulate the transcription level of VEGF mRNA and miRNA-21 genes. Furthermore, GP combined with microcapsules could accelerate wound healing and promote neovascularization.


Subject(s)
Capsules/chemistry , Glycyrrhiza uralensis/chemistry , Macromolecular Substances/chemistry , Polysaccharides/chemistry , Wound Healing , Animals , Capsules/therapeutic use , Chemical Phenomena , Macromolecular Substances/therapeutic use , Models, Animal , Neovascularization, Physiologic , Rats , Solubility , Spectrum Analysis
13.
Macromol Biosci ; 20(5): e1900445, 2020 05.
Article in English | MEDLINE | ID: mdl-32196951

ABSTRACT

Monoclonal antibodies (mAbs) against B cell antigens are extensively used in the treatment of rheumatoid arthritis (RA). The B cell depletion therapy prevents RA symptoms and/or alleviates existing inflammation. The previously established two-step drug-free macromolecular therapeutics (DFMT) is applied in the treatment of collagen-induced rheumatoid arthritis in a collagen-induced rheumatoid arthritis mouse model. DFMT is a B cell depletion strategy utilizing Fab' fragment of anti-CD20 mAb for biorecognition and receptor crosslinking to induce B cell apoptosis. DFMT is composed from two nanoconjugates: 1) bispecific engager, Fab'-MORF1 (anti-CD20 Fab' fragment conjugated with morpholino oligonucleotide MORF1), and 2) a crosslinking (effector) component P-(MORF2)X (N-(2-hydroxypropyl)methacrylamide copolymer grafted with multiple copies of complementary morpholino oligonucleotide MORF2). The absence of Fc fragment has the potential to avoid development of resistance and infusion-related reactions. DFMT produces B cell depletion, keeps the RA score low for more than 100 days, and shows minimal cartilage and bone erosion and inflammatory cell infiltration. Further improvements will be explored to optimize DFMT strategy in autoimmune disease treatment.


Subject(s)
Arthritis, Rheumatoid/chemically induced , Arthritis, Rheumatoid/therapy , Collagen/adverse effects , Macromolecular Substances/therapeutic use , Animals , Arthritis, Rheumatoid/pathology , B-Lymphocytes/immunology , Body Weight , Disease Models, Animal , Joints/diagnostic imaging , Joints/pathology , Lymphocyte Depletion , Male , Mice, Inbred DBA , Nanoparticles/chemistry , Polymers/chemistry , X-Ray Microtomography
14.
Int J Biol Macromol ; 151: 1-18, 2020 May 15.
Article in English | MEDLINE | ID: mdl-32035954

ABSTRACT

Marine biome exhibits an immense essence of excellence and enriched with high-value bioactive compounds of therapeutic and biomedical value. During the past several years, an array of biologically active molecules has been extracted/isolated and purified from numerous sources of marine origin with the aid of distinct techniques and methodologies for newer applications. The growing demand for bioactive molecules with unique functionalities in various industrial divisions, such as therapeutic sectors and biomedical, has endorsed the necessity for highly suitable and standardized strategies to extract these bioactive components using a state-of-the-art and inexpensive measures. This is also because many in practice conventional extraction methodologies suffer from processing limitations and low-yield issues. Besides that, other major issues include (i) decrease efficacy, (ii) excessive energy cost, (iii) low yield, (iv) lower cost-effective ratio, (v) minimal selectivity, (vi) low activity, and (vii) stability, etc. In this context, there is an urgent need for new and robust extraction strategies. The synergies of modern extraction techniques with efficient and novel pretreatment approaches, such as the integration of enzymes, accompanied by conventional extraction processes, should be the utmost goal of current research and development studies. The typical effectivity of the extraction techniques mostly relies on these points, i.e., (i) know-how about the source nature and type, (ii) understanding the structural and compositional profile, (iii) influence of the processing factors, (iv) interplay between the extraction conditions and the end-product, (v) understanding the available functional entities, (vi) reaction chemistry of the extract bioactive compounds, and (vii) effective exploitation of the end-product in the marketplace. Marine biome, among numerous naturally occurring sources, has been appeared an immense essence of excellence to isolate an array of biologically active constituents with medicinal values and related point-of-care applications. Herein, we reviewed the salient information covering various therapeutic potential and biomedical perspectives. Following a brief introduction and marine pharmacognosy, an array of high-value biomolecules of marine origin are discussed with suitable examples. From the robust extraction strategies viewpoint, a part of the review focuses on three techniques, i.e., (1) enzyme-assisted extraction (EAE), (2) supercritical-fluid extraction (SFE), and (3) microwave-assisted extraction (MAE). Each technique is further enriched with processing and workflow environment. The later part of the review is mainly focused on the therapeutic and biomedical perspectives of under-reviewed bio-active compounds or biomolecules. The previous and latest research on the anticancer, skin curative, cardio-protective, immunomodulatory and UV-protectant potentialities of marine-derived biologically active entities have been summarized with suitable examples and related pathways illustrations. Finally, the work is wrapped-up with current research challenges, future aspects, and concluding remarks.


Subject(s)
Biological Products/pharmacology , Macromolecular Substances/pharmacology , Animals , Aquatic Organisms/chemistry , Biological Products/chemistry , Biological Products/isolation & purification , Biological Products/therapeutic use , Biomedical Research , Chemical Fractionation , Drug Discovery , Ecosystem , Humans , Macromolecular Substances/chemistry , Macromolecular Substances/isolation & purification , Macromolecular Substances/therapeutic use , Structure-Activity Relationship
15.
J Mater Chem B ; 8(4): 715-726, 2020 01 28.
Article in English | MEDLINE | ID: mdl-31868869

ABSTRACT

Self-assembled supramolecular gels as a soft material have received extensive attention due to their excellent physicochemical properties such as variability, multiple responsiveness and appropriate viscoelasticity. At present, many self-assembled gels with physicochemical functions are constructed as drug delivery systems and used for the treatment of diseases. However, self-assembled gel drug delivery systems having pharmacological functions remain almost unexplored. Here, we present an anti-inflammatory pharmacologically active gel drug delivery system consisting of direct self-assembled small molecule naturally-occurring compounds (self-assembled small molecule natural products, SSNPs) derived from traditional Chinese medicine. The system not only exhibits excellent thixotropy, good topical safety and sustained release, but also achieves superior inflammatory therapeutic effects both in vivo and in vitro. Compared to non-pharmacologically active drug delivery systems, this system can increase the in vivo anti-inflammatory activity of drugs by nearly two-thirds. More importantly, its therapeutic effect even reached 141.54% of OTC drugs. The successful construction of an anti-inflammatory pharmacologically active gel drug delivery system not only makes full use of the self-assembly properties and biological activity of natural products, but also provides an important reference for the development of pharmacologically active drug delivery systems using SSNPs in the future.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Biological Products/therapeutic use , Drug Delivery Systems , Edema/drug therapy , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/isolation & purification , Biological Products/chemistry , Biological Products/isolation & purification , Edema/chemically induced , Gels/chemistry , Gels/isolation & purification , Gels/therapeutic use , Liquidambar/chemistry , Macromolecular Substances/chemistry , Macromolecular Substances/isolation & purification , Macromolecular Substances/therapeutic use , Materials Testing , Medicine, Chinese Traditional , Mice , Mice, Inbred Strains , Molecular Conformation , RAW 264.7 Cells , Xylenes
16.
Colloids Surf B Biointerfaces ; 181: 657-670, 2019 Sep 01.
Article in English | MEDLINE | ID: mdl-31212138

ABSTRACT

Supramolecular hydrogels were synthesized using a bis-imidazolium based amphiphile, and incorporating chemically diverse drugs, such as the cytostatics gemcitabine hydrochloride and methotrexate sodium salt, the immunosuppressive drug tacrolimus, as well as the corticoid drugs betamethasone 17-valerate and triamcinolone acetonide, and their potential as drug delivery agents in the dermal treatment of Psoriasis was evaluated. The rheological behavior of gels was studied, showing in all cases suitable viscoelastic properties for topical drug delivery. Scanning electron microscopy (SEM) shows that the drugs included have a great influence on the gel morphology at the microscopic level, as the incorporation of gemcitabine hydrochloride leads to slightly thicker fibers, the incorporation of tacrolimus induces flocculation and spherical precipitates, and the incorporation of methotrexate forms curled fibers. 1H NMR spectroscopy experiments show that these drugs not only remain dissolved at the interstitial space, but up to 72% of either gemcitabine or methotrexate, and up to 38% of tacrolimus, is retained within the gel fibers in gels formed with a 1:1 gelator:drug molar ratio. This unique fiber incorporation not only protects the drug from degradation, but also importantly induces a Two Phase Exponential drug release, where the first phase corresponds to the drug dissolved in the interstitial space, while the second phase corresponds to the drug exiting from the gel fibers, and where the speed in each phase is in accordance with the physicochemical properties of the drugs, opening perspectives for controlled delivery. Skin permeation ex vivo tests show how these gels successfully promote the drug permeation and retention inside the skin for reaching their therapeutic target, while in vivo experiments demonstrate that they decrease the hyperplasia and reduce the macroscopic tissue damage typically observed in psoriatic skin, significantly more than the drugs in solution. All these characteristics, beside the spontaneous and easy preparation (room temperature and soft stirring), make these gels a good alternative to other routes of administration for Psoriasis treatment, increasing the drug concentration at the target tissue, and minimizing side effects.


Subject(s)
Hydrogels/chemistry , Hydrogels/therapeutic use , Macromolecular Substances/therapeutic use , Nanostructures/therapeutic use , Psoriasis/drug therapy , Skin Diseases/drug therapy , Administration, Topical , Adult , Animals , Female , Humans , Hydrogels/administration & dosage , Macromolecular Substances/administration & dosage , Macromolecular Substances/chemistry , Male , Mice , Molecular Structure , Nanostructures/administration & dosage , Nanostructures/chemistry , Particle Size , Psoriasis/pathology , Skin/drug effects , Skin/metabolism , Skin/pathology , Skin Absorption/drug effects , Skin Diseases/pathology , Surface Properties
17.
Adv Drug Deliv Rev ; 136-137: 2-27, 2018.
Article in English | MEDLINE | ID: mdl-30359631

ABSTRACT

Current treatments for intestinal diseases including inflammatory bowel diseases, irritable bowel syndrome, and colonic bacterial infections are typically small molecule oral dosage forms designed for systemic delivery. The intestinal permeability hurdle to achieve systemic delivery from oral formulations of macromolecules is challenging, but this drawback can be advantageous if an intestinal region is associated with the disease. There are some promising formulation approaches to release peptides, proteins, antibodies, antisense oligonucleotides, RNA, and probiotics in the colon to enable local delivery and efficacy. We briefly review colonic physiology in relation to the main colon-associated diseases (inflammatory bowel disease, irritable bowel syndrome, infection, and colorectal cancer), along with the impact of colon physiology on dosage form design of macromolecules. We then assess formulation strategies designed to achieve colonic delivery of small molecules and concluded that they can also be applied some extent to macromolecules. We describe examples of formulation strategies in preclinical research aimed at colonic delivery of macromolecules to achieve high local concentration in the lumen, epithelial-, or sub-epithelial tissue, depending on the target, but with the benefit of reduced systemic exposure and toxicity. Finally, the industrial challenges in developing macromolecule formulations for colon-associated diseases are presented, along with a framework for selecting appropriate delivery technologies.


Subject(s)
Colon/metabolism , Colonic Diseases/drug therapy , Drug Delivery Systems , Macromolecular Substances/administration & dosage , Macromolecular Substances/pharmacokinetics , Humans , Macromolecular Substances/therapeutic use
18.
Nat Commun ; 9(1): 1815, 2018 05 08.
Article in English | MEDLINE | ID: mdl-29739936

ABSTRACT

Nested concentric structures widely exist in nature and designed systems with circles, polygons, polyhedra, and spheres sharing the same center or axis. It still remains challenging to construct discrete nested architecture at (supra)molecular level. Herein, three generations (G2-G4) of giant nested supramolecules, or Kandinsky circles, have been designed and assembled with molecular weight 17,964, 27,713 and 38,352 Da, respectively. In the ligand preparation, consecutive condensation between precursors with primary amines and pyrylium salts is applied to modularize the synthesis. These discrete nested supramolecules are prone to assemble into tubular nanostructures through hierarchical self-assembly. Furthermore, nested supramolecules display high antimicrobial activity against Gram-positive pathogen methicillin-resistant Staphylococcus aureus (MRSA), and negligible toxicity to eukaryotic cells, while the corresponding ligands do not show potent antimicrobial activity.


Subject(s)
Anti-Bacterial Agents/chemistry , Macromolecular Substances/chemistry , Methicillin-Resistant Staphylococcus aureus/drug effects , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Drug Resistance, Bacterial , Hydrophobic and Hydrophilic Interactions , Ligands , Macromolecular Substances/pharmacology , Macromolecular Substances/therapeutic use , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Microbial Sensitivity Tests , Microscopy, Atomic Force , Microscopy, Electron, Transmission , Molecular Weight , Nanostructures , Proton Magnetic Resonance Spectroscopy , Staphylococcal Infections/drug therapy , Staphylococcal Infections/microbiology
20.
Nat Commun ; 9(1): 917, 2018 03 02.
Article in English | MEDLINE | ID: mdl-29500445

ABSTRACT

Polymyxins remain the last line treatment for multidrug-resistant (MDR) infections. As polymyxins resistance emerges, there is an urgent need to develop effective antimicrobial agents capable of mitigating MDR. Here, we report biodegradable guanidinium-functionalized polycarbonates with a distinctive mechanism that does not induce drug resistance. Unlike conventional antibiotics, repeated use of the polymers does not lead to drug resistance. Transcriptomic analysis of bacteria further supports development of resistance to antibiotics but not to the macromolecules after 30 treatments. Importantly, high in vivo treatment efficacy of the macromolecules is achieved in MDR A. baumannii-, E. coli-, K. pneumoniae-, methicillin-resistant S. aureus-, cecal ligation and puncture-induced polymicrobial peritonitis, and P. aeruginosa lung infection mouse models while remaining non-toxic (e.g., therapeutic index-ED50/LD50: 1473 for A. baumannii infection). These biodegradable synthetic macromolecules have been demonstrated to have broad spectrum in vivo antimicrobial activity, and have excellent potential as systemic antimicrobials against MDR infections.


Subject(s)
Bacterial Infections/drug therapy , Bacterial Infections/microbiology , Drug Resistance, Multiple, Bacterial , Macromolecular Substances/therapeutic use , Animals , Anti-Infective Agents/pharmacology , Bacteria/drug effects , Bacteria/isolation & purification , Cecum/surgery , Disease Models, Animal , Drug Resistance, Multiple, Bacterial/drug effects , Female , Hemolysis/drug effects , Kinetics , Ligation , Macromolecular Substances/pharmacokinetics , Male , Mice, Inbred C57BL , Mice, Inbred ICR , Microbial Sensitivity Tests , Polymers/chemical synthesis , Polymers/chemistry , Polymers/pharmacokinetics , Polymers/therapeutic use , Punctures , Sequence Analysis, RNA , Tissue Distribution/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...